﹤Biotech & Biomed Innovation﹥Thrombomodulin & miRNA for Osteoarthritis Prevention
Kaohsiung Medical University / Prof. Tsung-Lin Cheng
Pain Points Solved
- Current treatments for osteoarthritis mainly relieve symptoms and are unable to repair damaged cartilage.
- Existing medications are associated with significant side effects and high risks with long-term use.
- Regenerative medicine approaches are costly and require advanced technical expertise.
- This technology utilizes thrombomodulin (TM) and its microRNA regulatory mechanism to promote cartilage repair, offering low cost, low allergenicity, and high safety, with the potential to address the disease at its root cause.
Technology Introduction
- Technical Background
Osteoarthritis (OA) affects tens of millions of people worldwide, causing cartilage damage and joint pain, yet there is currently no effective treatment. This technology focuses on thrombomodulin (TM), a highly evolutionarily conserved protein.
- Technical Description and Advantages
TM can promote chondrocyte growth and inhibit inflammation. By injecting TM or enhancing its expression through microRNA (miR-up-TM), OA can be effectively prevented or treated. This technology is cost-effective, easy to use, and reduces the risk of allergic reactions.

Figure 1. Role of thrombomodulin (TM) in chondrocytes and osteoarthritis (OA).

Figure 1. miR-up-TM enhances the signaling pathway from KLF2 to TM, thereby effectively protecting knee joint functio.

Figure 1. miR-up-TM increases TM expression in chondrocytes to exert anti-osteoarthritic effects.
Application Examples
- Local injection of TM protein can suppress inflammation and promote chondrocyte regeneration, thereby improving joint mobility.
- Application of miR-up-TM technology enhances endogenous TM expression to prevent the progression of degenerative osteoarthritis.
- This technology can be extended to cartilage repair implants or regenerative medicine products, facilitating the treatment of sports injuries and joint reconstruction.
Related Links
None
Patent Name and Number
TW 113116868
US 18/656,60822
Industry-Academia / Tech Transfer Partner
None
Honors and Awards
21st National Innovation Award-Academia & Research Innovation Award
Technical Contact
Mr. Hung, Assistant Manager
Kaohsiung Medical University
Tel: +886 7-3121101 ext. 2360
Email: R121084@kmu.edu.tw

